Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pizotifen malate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pizotifen 500microgram tablets
0407042Q0AAABAB
|
Pizotifen malate | Pizotifen malate | Central Nervous System | 62,560 |
|
Pizotifen 1.5mg tablets
0407042Q0AAACAC
|
Pizotifen malate | Pizotifen malate | Central Nervous System | 55,082 |
|
Pizotifen 250micrograms/5ml oral suspension
0407042Q0AAAEAE
|
Pizotifen malate | Pizotifen malate | Central Nervous System | 179 |
|
Pizotifen 250micrograms/5ml oral solution
0407042Q0AAADAD
|
Pizotifen malate | Pizotifen malate | Central Nervous System | 70 |
|
Pizotifen 1mg/5ml oral suspension
0407042Q0AAAHAH
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 250micrograms/5ml oral solution sugar free
0407042Q0AAAAAA
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 500micrograms/5ml oral suspension
0407042Q0AAAFAF
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 750micrograms/5ml oral suspension
0407042Q0AAAGAG
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Sanomigran 0.25mg/5ml elixir
0407042Q0BBACAA
|
Sanomigran | Pizotifen malate | Central Nervous System | No data available |
|
Sanomigran 1.5mg tablets
0407042Q0BBABAC
|
Sanomigran | Pizotifen malate | Central Nervous System | No data available |
|
Sanomigran 500microgram tablets
0407042Q0BBAAAB
|
Sanomigran | Pizotifen malate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.